首页> 外国专利> method of predicting the effectiveness of treatment of the patients with psoriasis u0438u043du0444u043bu0438u043au0441u0438u043cu0430u0431u043eu043c

method of predicting the effectiveness of treatment of the patients with psoriasis u0438u043du0444u043bu0438u043au0441u0438u043cu0430u0431u043eu043c

机译:牛皮癣患者的治疗效果的预测方法

摘要

the invention belongs to the field of medicine.namely, dermatology and is a way to predict the effectiveness of treatment of patients with psoriasis by determining the molecular u0438u043du0444u043bu0438u043au0441u0438u043cu0430u0431u043eu043c sta skin biopsy specimens and serum shelter avaand psoriasis patients before starting treatment, production and research u0431u0438u043eu043fu0442u0430u0442u0430 skin and blood serum of psoriasis patients.the definition in the u0431u0438u043eu043fu0442u0430u0442u0435 skin polymorphism in position during the sixth u044du043au0437u043eu043du0430 gene TNF - r - ii, determine the content of il - 10 in serum.in order to u0433u043eu043cu043eu0437u0438u0433u043eu0442u043du043eu0433u043e genotyping tt in position during the sixth u044du043au0437u043eu043du0430 gene TNF - r - ii and high ( 2.7 ng / ml), the content of il - 10 in serum predict the effectiveness of le of,and in identifying the u0433u043eu043cu043eu0437u0438u0433u043eu0442u043du043eu0433u043e genotyping gg position 676 sixth u044du043au0437u043eu043du0430 gene TNF - r - ii and low ( 1.0 pg / ml), the content of il - 10 in serum predict low efficiency u043bu0435u0447u0435u043d whoa.this method saves considerable material resources spent on treatment, but also avoid the side effects of therapy.
机译:本发明属于医学领域,即皮肤病学,是一种通过确定分子 u0438 u043d u0444 u043b u0438 u043a u0441 u0438 u043c u0430来预测牛皮癣患者治疗效果的方法开始治疗,生产和研究牛皮癣患者的皮肤活检标本和血清庇护所和银屑病患者之前,银屑病患者的皮肤和血清血清的定义。在第六个 u044d u043a u0437 u043e u043d u04d u0430基因TNF-r-ii期间,确定 u0431 u0438 u043e u043f u0442 u0430 u0442 u0435皮肤多态性的位置,确定il-10的含量为了在第六个 u044d u043a u0437 u043e u043d u043d u043e u043c u043e u0437 u0438 u0433 u043e u0442 u043d u043e u0433 u043e基因分型tt处于适当位置u0430基因TNF-r-ii和高(> 2.7 ng / ml),血清中il-10的含量预测了le的有效性,并鉴定了u0430。 043e u043c u043e u0437 u0438 u0433 u043e u0442 u043d u043e u0433 u043e基因分型gg位置676第六 u044d u043a u0437 u043e u043d u043d u0430基因TNF-r-ii和低(< (1.0 pg / ml),血清中il-10的含量预测效率低。这种方法节省了可观的治疗用物质资源,而且避免了治疗的副作用。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号